Promotion of axonal regeneration in the injured CNS

Lancet Neurology

Volumn 2, Issue 3, 2003, Pages 157-166

  Selzer, Michael E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; NEUROMODULIN;

CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CYTOSKELETON; HEALTH PROMOTION; HUMAN; MACROPHAGE; MICROTUBULE; NERVE CELL; NERVE FIBER GROWTH; NERVE FIBER TRANSECTION; NERVE GRAFT; NERVE REGENERATION; PRIORITY JOURNAL; REDUCTION; REVIEW; SPINAL CORD INJURY; STEM CELL; TRANSPLANTATION; ANIMAL; BRAIN INJURY; CLINICAL TRIAL; NERVE FIBER; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; AXONS; BRAIN INJURIES; CLINICAL TRIALS; HUMANS; NERVE REGENERATION; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 0041851002     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00322-3     Document Type: Review

References (140)

1. Giehl K.M. Trophic dependencies of rodent corticospinal neurons. Rev Neurosci. 12:2001;79-94.
2. Ramón y Cajal S. Degeneration and regeneration of the nervous system. 1928;Hafner Press, New York.
3. Kao C.C., Chang L.W., Bloodworth J.M. Jr. Electron microscopic observations of the mechanisms of terminal club formation in transected spinal cord axons. J Neuropathol Exp Neurol. 36:1977;140-156.
4. Schmidt R.E., Plurad S.B. Ultrastructural appearance of intentionally frustrated axonal regeneration in rat sciatic nerve. J Neuropathol Exp Neurol. 44:1985;130-146.
5. Bentley D., O'Connor T.P. Cytoskeletal events in growth cone steering. Curr Opin Neurobiol. 4:1994;43-48.
6. Yin H.S., Selzer M.E. Axonal regeneration in lamprey spinal cord. J Neurosci. 3:1983;1135-1144.
7. Hall G.F., Yao J., Selzer M.E., Kosik K.S. Cytoskeletal changes correlated with the loss of neuronal polarity in axotomized lamprey central neurons. J Neurocytol. 26:1997;733-753.
8. Cai D., Qiu J., Cao Z., McAtee M., Bregman B.S., Filbin M.T. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci. 21:2001;4731-4739.
9. Dong J.M., Leung T., Manser E., Lim L. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J Biol Chem. 273:1998;22554-22562.
10. Qiu J., Cai D., Dai H., et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron. 34:2002;895-903.
11. Wang K.C., Koprivica V., Kim J.A., et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:2002;941-944.
12. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346.
13. Liu B.P., Fournier A., GrandPre T., Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the nogo-66 receptor. Science. 297:2002;1190-1193.
14. Lehmann M., Fournier A., Selles-Navarro I., et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci. 19:1999;7537-7547.
15. Liu B.P., Strittmatter S.M. Semaphorin-mediated axonal guidance via Rho-related G proteins. Curr Opin Cell Biol. 13:2001;619-626.
16. Jacobs A.J., Swain G.P., Snedeker J.A., Pijak D.S., Gladstone L.J., Selzer M.E. Recovery of neurofilament expression selectively in regenerating reticulospinal neurons. J Neurosci. 17:1997;5206-5220.
17. Shifman M.I., Selzer M.E. Expression of the netrin receptor UNC-5 in lamprey brain: modulation by spinal cord transection. Neurorehabil Neural Repair. 14:2000;49-58.
18. Chalasani SH, Sabelko KA, Sunshine MJ, Littman DR, Raper JA. A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. J Neurosci (in press).
19. Lurie D.I., Pijak D.S., Selzer M.E. Structure of reticulospinal axon growth cones and their cellular environment during regeneration in the lamprey spinal cord. J Comp Neurol. 344:1994;559-580.
20. Lanners H.N., Grafstein B. Early stages of axonal regeneration in the goldfish optic tract: an electron microscopic study. J Neurocytol. 9:1980;733-751.
21. Scalia F., Matsumoto D.E. The morphology of growth cones of regenerating optic nerve axons. J Comp Neurol. 231:1985;323-338.
22. Gocht A., Löhler J. Microenvironmental changes during axonal regrowth in the optic nerve of the myelin deficient rat: immunocytochemical and ultrastructural observations. J Neurocytol. 22:1993;461-479.
23. Goldberg J.L., Klassen M.P., Hua Y., Barres B.A. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science. 296:2002;1860-1864.
24. Vidal-Sanz M., Bray G.M., Villegas-Perez M.P., Thanos S., Aguayo A.J. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci. 7:1987;2894-2909.
25. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature. 343:1990;269-272.
26. Sperry R.W. Optic nerve regeneration with return of vision in anurans. J Neurophysiol. 7:1944;57-69.
27. Gaze R.M., Jacobson M. A study of the retino-tectal projection during regeneration of the optic nerve in the frog. Proc Roy Soc Lond. 157:1963;420-448.
28. O'Leary D.D., Wilkinson D.G. Eph receptors and ephrins in neural development. Curr Opin Neurobiol. 9:1999;65-73.
29. Mackler S.A., Yin H.S., Selzer M.E. Determinants of directional specificity in the regeneration of lamprey spinal axons. J Neurosci. 6:1986;1814-1821.
30. Mackler S.A., Selzer M.E. Specificity of synaptic regeneration in the spinal cord of the larval sea lamprey. J Physiol (Lond). 388:1987;183-198.
31. David S., Aguayo A.J. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science. 214:1981;931-933.
32. Friedman B., Aguayo A.J. Injured neurons in the olfactory bulb of the adult rat grow axons along grafts of peripheral nerve. J Neurosci. 5:1985;1616-1625.
33. Richardson P.M., McGuinness U.M., Aguayo A.J. Axons from CNS neurons regenerate into PNS grafts. Nature. 284:1980;264-265.
34. Fournier A.E., Strittmatter S.M. Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol. 11:2001;89-94.
35. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1:1988;85-96.
36. Chen M.S., Huber A.B., van der Haar M.E., et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
37. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
38. Prinjha R., Moore S.E., Vinson M., et al. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
39. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:1994;805-811.
40. Becker C.G., Becker T., Meyer R.L., Schachner M. Tenascin-R inhibits the growth of optic fibers in vitro but is rapidly eliminated during nerve regeneration in the salamander Pleurodeles waltl. J Neurosci. 19:1999;813-827.
41. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res Bull. 49:1999;377-391.
42. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci. 11:1991;3398-3411.
43. Davies S.J., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature. 390:1997;680-683.
44. Davies S.J., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci. 19:1999;5810-5822.
45. Becker T., Bernhardt R.R., Reinhard E., Wullimann M.F., Tongiorgi E., Schachner M. Readiness of zebrafish brain neurons to regenerate a spinal axon correlates with differential expression of specific cell recognition molecules. J Neurosci. 18:1998;5789-5803.
46. Chen D.F., Jhaveri S., Schneider G.E. Intrinsic changes in developing retinal neurons result in regenerative failure of their axons. Proc Nat Acad Sci USA. 92:1995;7287-7291.
47. Bray G.M., Villegas-Perez M.P., Vidal-Sanz M., Aguayo A.J. The use of peripheral nerve grafts to enhance neuronal survival, promote growth and permit terminal reconnections in the central nervous system of adult rats. J Exp Biol. 132:1987;5-19.
48. Bonilla I.E., Tanabe K., Strittmatter S.M. Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci. 22:2002;1303-1315.
49. Skene J.H., Willard M. Characteristics of growth-associated polypeptides in regenerating toad retinal ganglion cell axons. J Neurosci. 1:1981;419-426.
50. Moya K.L., Benowitz L.I., Jhaveri S., Schneider G.E. Changes in rapidly transported proteins in developing hamster retinofugal axons. J Neurosci. 8:1988;4445-4454.
51. Hoffman P.N. Expression of GAP-43, a rapidly transported growth-associated protein, and class II beta tubulin, a slowly transported cytoskeletal protein, are coordinated in regenerating neurons. J Neurosci. 9:1989;893-897.
52. Doster S.K., Lozano A.M., Aguayo A.J., Willard M.B. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron. 6:1991;635-647.
53. Andersen L.B., Schreyer D.J. Constitutive expression of GAP-43 correlates with rapid, but not slow regrowth of injured dorsal root axons in the adult rat. Exp Neurol. 155:1999;157-164.
54. Strata P., Buffo A., Rossi F. Mechanisms of axonal plasticity. Arch Ital Biol. 137:1999;181-192.
55. Buffo A., Holtmaat A.J., Savio T., et al. Targeted overexpression of the neurite growth-associated protein B- 50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci. 17:1997;8778-8791.
56. Mason M.R., Campbell G., Caroni P., Anderson P.N., Lieberman A.R. Overexpression of GAP-43 in thalamic projection neurons of transgenic mice does not enable them to regenerate axons through peripheral nerve grafts. Exp Neurol. 165:2000;143-152.
57. Bomze H.M., Bulsara K.R., Iskandar B.J., Caroni P., Skene J.H. Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons. Nat Neurosci. 4:2001;38-43.
58. Udvadia A.J., Koster R.W., Skene J.H. GAP-43 promoter elements in transgenic zebrafish reveal a difference in signals for axon growth during CNS development and regeneration. Development. 128:2001;1175-1182.
59. Muma N.A., Hoffman P.N., Slunt H.H., Applegate M.D., Lieberburg I., Price D.L. Alterations in levels of mRNAs coding for neurofilament protein subunits during regeneration. Exp Neurol. 107:1990;230-235.
60. Bisby M.A., Tetzlaff W. Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration. Mol Neurobiol. 6:1992;107-123.
61. Marsh L., Letourneau P.C. Growth of neurites without filopodial or lamellipodial activity in the presence of cytochalasin B. J Cell Biol. 99:1984;2041-2047.
62. Tesser P., Jones P.S., Schechter N. Elevated levels of retinal neurofilament mRNA accompany optic nerve regeneration. J Neurochem. 47:1986;1235-1243.
63. McKerracher L., Vidal-Sanz M., Aguayo A.J. Slow transport rates of cytoskeletal proteins change during regeneration of axotomized retinal neurons in adult rats. J Neurosci. 10:1990;641-648.
64. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci. 22:2002;6570-6577.
65. Cai D., Deng K., Mellado W., Lee J., Ratan R.R., Filbin M.T. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 35:2002;711-719.
66. Kao H.T., Song H.J., Porton B., et al. A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat Neurosci. 5:2002;431-437.
67. Ming G.L., Song H.J., Berninger B., Holt C.E., Tessier-Lavigne M., Poo M.M. cAMP-dependent growth cone guidance by netrin-1. Neuron. 19:1997;1225-1235.
68. Sebok A., Nusser N., Debreceni B., et al. Different roles for RhoA during neurite initiation, elongation, and regeneration in PC12 cells. J Neurochem. 73:1999;949-960.
69. Aviles-Trigueros M., Sauve Y., Lund R.D., Vidal-Sanz M. Selective innervation of retinorecipient brainstem nuclei by retinal ganglion cell axons regenerating through peripheral nerve grafts in adult rats. J Neurosci. 20:2000;361-374.
70. Whiteley S.J., Sauve Y., Aviles-Trigueros M., Vidal-Sanz M., Lund R.D. Extent and duration of recovered pupillary light reflex following retinal ganglion cell axon regeneration through peripheral nerve grafts directed to the pretectum in adult rats. Exp Neurol. 154:1998;560-572.
71. Sasaki H., Inoue T., Iso H., Fukuda Y., Hayashi Y. Light-dark discrimination after sciatic nerve transplantation to the sectioned optic nerve in adult hamsters. Vision Res. 33:1993;877-880.
72. Cheng H., Cao Y., Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science. 273:1996;510-513.
73. Tessler A., Fischer I., Giszter S., et al. Embryonic spinal cord transplants enhance locomotor performance in spinalized newborn rats. Adv Neurol. 72:1997;291-303.
74. Coumans J.V., Lin T.T., Dai H.N., et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J Neurosci. 21:2001;9334-9344.
75. Gage F.H., Ray J., Fisher L.J. Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci. 18:1995;159-192.
76. Mayer-Proschel M., Kalyani A.J., Mujtaba T., Rao M.S. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron. 19:1997;773-785.
77. McDonald J.W., Liu X.Z., Qu Y., et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 5:1999;1410-1412.
78. Liu Y., Himes B.T., Solowska J., et al. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp Neurol. 158:1999;9-26.
79. Rao M.S., Mayer-Proschel M. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol. 188:1997;48-63.
80. Pleasure S.J., Page C., Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci. 12:1992;1802-1815.
81. Guest J.D., Rao A., Olson L., Bunge M.B., Bunge R.P. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Experimental Neurology. 148:1997;502-522.
82. Ramon-Cueto A., Plant G.W., Avila J., Bunge M.B. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci. 18:1998;3803-3815.
83. Tuszynski M.H., Peterson D.A., Ray J., Baird A., Nakahara Y., Gage F.H. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol. 126:1994;1-14.
84. Blesch A., Uy H.S., Grill R.J., Cheng J.G., Patterson P.H., Tuszynski M.H. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci. 19:1999;3556-3566.
85. Liu Y., Kim D., Himes B.T., et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci. 19:1999;4370-4387.
86. Cao Q.L., Zhang Y.P., Howard R.M., Walters W.M., Tsoulfas P., Whittemore S.R. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol. 167:2001;48-58.
87. Shihabuddin L.S., Horner P.J., Ray J., Gage F.H. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci. 20:2000;8727-8735.
88. Franklin R.J., Bayley S.A., Milner R., Ffrench-Constant C., Blakemore W.F. Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter. Glia. 13:1995;39-44.
89. Hammang J.P., Archer D.R., Duncan I.D. Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp Neurol. 147:1997;84-95.
90. Liu S., Qu Y., Stewart T.J., et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA. 97:2000;6126-6131.
91. Keirstead H.S., Ben-Hur T., Rogister B., O'Leary M.T., Dubois-Dalcq M., Blakemore W.F. Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation. J Neurosci. 19:1999;7529-7536.
92. Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol. 148:1997;587-603.
93. Jones L.L., Yamaguchi Y., Stallcup W.B., Tuszynski M.H. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci. 22:2002;2792-2803.
94. Schwartz M., Cohen I., Lazarov-Spiegler O., Moalem G., Yoles E. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J Mol Med. 77:1999;713-717.
95. Barouch R., Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 16:2002;1304-1306.
96. Lazarov-Spiegler O., Solomon A.S., Schwartz M. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia. 24:1998;329-337.
97. Takami T., Oudega M., Bates M.L., Wood P.M., Kleitman N., Bunge M.B. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci. 22:2002;6670-6681.
98. Brosamle C., Huber A.B., Fiedler M., Skerra A., Schwab M.E. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J Neurosci. 20:2000;8061-8068.
99. Merkler D., Metz G.A., Raineteau O., Dietz V., Schwab M.E., Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci. 21:2001;3665-3673.
100. Thallmair M., Metz G.A., Z'Graggen W.J., Raineteau O., Kartje G.L., Schwab M.E. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat Neurosci. 1:1998;124-131.
101. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:2002;547-551.
102. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:1994;757-767.
103. Bartsch U., Bandtlow C.E., Schnell L., et al. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron. 15:1995;1375-1381.
104. Huang D.W., McKerracher L., Braun P.E., David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron. 24:1999;639-647.
105. Bradbury E.J., Moon L.D., Popat R.J., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
106. Tuszynski M.H., Gage F.H. Maintaining the neuronal phenotype after injury in the adult CNS: neurotrophic factors, axonal growth substrates, and gene therapy. Mol Neurobiol. 10:1995;151-167.
107. Ye J.H., Houle J.D. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol. 143:1997;70-81.
108. Himes B.T., Liu Y., Solowska J.M., Snyder E.Y., Fischer I., Tessler A. Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats. J Neurosci Res. 65:2001;549-564.
109. Houle J.D., Ye J.H. Survival of chronically-injured neurons can be prolonged by treatment with neurotrophic factors. Neuroscience. 94:1999;929-936.
110. Bregman B.S., Broude E., McAtee M., Kelley M.S. Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury. Exp Neurol. 149:1998;13-27.
111. Bregman B.S., McAtee M., Dai H.N., Kuhn P.L. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol. 148:1997;475-494.
112. Schnell L., Schneider R., Kolbeck R., Barde Y.A., Schwab M.E. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature. 367:1994;170-173.
113. Iwaya K., Mizoi K., Tessler A., Itoh Y. Neurotrophic agents in fibrin glue mediate adult dorsal root regeneration into spinal cord. Neurosurgery. 44:1999;589-595.
114. Ramer M.S., Priestley J.V., McMahon S.B. Functional regeneration of sensory axons into the adult spinal cord. Nature. 403:2000;312-316.
115. Oudega M., Hagg T. Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord. Brain Res. 818:1999;431-438.
116. Blesch A., Tuszynski M.H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol. 148:1997;444-452.
117. Cai D., Shen Y., De Bellard M., Tang S., Filbin M.T. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron. 22:1999;89-101.
118. Kwon B.K., Liu J., Messerer C., et al. Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc Natl Acad Sci USA. 99:2002;3246-3251.
119. Shibata M., Murray M., Tessler A., Ljubetic C., Connors T., Saavedra R.A. Single injections of a DNA plasmid that contains the human Bcl-2 gene prevent loss and atrophy of distinct neuronal populations after spinal cord injury in adult rats. Neurorehabil Neural Repair. 14:2000;319-330.
120. Dubois-Dauphin M., Frankowski H., Tsujimoto Y., Huarte J., Martinou J.C. Neonatal motoneurons overexpressing the Bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci USA. 91:1994;3309-3313.
121. Takahashi K., Schwarz E., Ljubetic C., Murray M., Tessler A., Saavedra R.A. DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats. J Comp Neurol. 404:1999;159-171.
122. Bonfanti L., Strettoi E., Chierzi S., et al. Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing Bcl-2. J Neurosci. 16:1996;4186-4194.
123. Chierzi S., Strettoi E., Cenni M.C., Maffei L. Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice. J Neurosci. 19:1999;8367-8376.
124. Xu Z., Dong D.L., Cleveland D.W. Neuronal intermediate filaments: new progress on an old subject. Curr Opin Neurobiol. 4:1994;655-661.
125. Lindvall O. Update on fetal transplantation: the Swedish experience. Mov Disord. 13:(suppl 1):1998;83-87.
126. Freeman T.B., Willing A., Zigova T., Sanberg P.R., Hauser R.A. Neural transplantation in Parkinson's disease. Adv Neurol. 86:2001;435-445.
127. Bachoud-Levi A.C., Remy P., Nguyen J.P., et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet. 356:2000;1975-1979.
128. Hauser R.A., Furtado S., Cimino C.R., et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology. 58:2002;687-695.
129. Tuszynski M.H., Thal L., U H.S., et al. Nerve growth factor gene therapy for Alzheimer's disease. J Mol Neurosci. 19:2002;207.
130. Meltzer C.C., Kondziolka D., Villemagne V.L., et al. Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery. 49:2001;586-591.
131. Thompson F.J., Reier P.J., Uthman B., et al. Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia. J Neurotrauma. 18:2001;931-945.
132. Falci S., Holtz A., Akesson E., et al. Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. J Neurotrauma. 14:1997;875-884.
133. Dietz V., Colombo G., Jensen L., Baumgartner L. Locomotor capacity of spinal cord in paraplegic patients. Ann Neurol. 37:1995;574-582.
134. Harkema S.J., Hurley S.L., Patel U.K., Requejo P.S., Dobkin B.H., Edgerton V.R. Human lumbosacral spinal cord interprets loading during stepping. J Neurophysiol. 77:1997;797-811.
135. Hesse S., Bertelt C., Jahnke M.T., et al. Treadmill training with partial body weight support compared with physiotherapy in nonambulatory hemiparetic patients. Stroke. 26:1995;976-981.
136. Visintin M., Barbeau H., Korner-Bitensky N., Mayo N.E. A new approach to retrain gait in stroke patients through body weight support and treadmill stimulation. Stroke. 29:1998;1122-1128.
137. Dobkin B.H., Harkema S., Requejo P., Edgerton V.R. Modulation of locomotor-like EMG activity in subjects with complete and incomplete spinal cord injury. J Neurol Rehabil. 9:1995;183-190.
138. Wernig A., Nanassy A., Muller S. Maintenance of locomotor abilities following Laufband (treadmill) therapy in para- and tetraplegic persons: follow-up studies. Spinal Cord. 36:1998;744-749.
139. Wirz M., Colombo G., Dietz V. Long term effects of locomotor training in spinal humans. J Neurol Neurosurg Psychiatry. 71:2001;93-96.
140. Dobkin BH. An overview of treadmill training with partial body weight support: a neurophysiologically sound approach whose time has come for randomized clinical trials. Neurorehabil Neural Repair 1999; 13: 157-55.